KeyBanc analyst issues OVERWEIGHT recommendation for URI on April 24, 2026 11:05AM ET. The previous analyst recommendation was Overweight.URI was trading at $986.78 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for URI on April 24, 2026 11:39AM ET. The previous analyst recommendation was Outperform.URI was trading at $986.78 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for DOV on April 24, 2026 11:44AM ET. The previous analyst recommendation was Outperform.DOV was trading at $228.15 at issue of the analyst recommendation.The overall...
Benchmark analyst issues BUY recommendation for APPF on April 24, 2026 11:45AM ET. The previous analyst recommendation was Buy.APPF was trading at $152.3 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for MPC on April 24, 2026 10:13AM ET. The previous analyst recommendation was Overweight.MPC was trading at $221.1 at issue of the analyst recommendation.The...
Wolfe Research analyst issues OUTPERFORM recommendation for TMHC on April 23, 2026 02:57PM ET. The previous analyst recommendation was Outperform.TMHC was trading at $64.07 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for LRCX on April 23, 2026 12:29PM ET. The previous analyst recommendation was Buy.LRCX was trading at $265.55 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for TMHC on April 23, 2026 12:26PM ET. The previous analyst recommendation was Outperform.TMHC was trading at $65 at issue of the analyst recommendation.The...
RBC Capital analyst issues OUTPERFORM recommendation for LRCX on April 23, 2026 12:49PM ET. The previous analyst recommendation was Outperform.LRCX was trading at $265.55 at issue of the analyst recommendation.The...
Goldman Sachs analyst issues BUY recommendation for LRCX on April 23, 2026 11:08AM ET. The previous analyst recommendation was Buy.LRCX was trading at $265.55 at issue of the analyst recommendation.The...
